The Medical and Surgical Practice of NaProTECHNOLOGY, 453-466, 2004
Chapter 36: Thyroid System Dysfunction
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
Both overt and subclinical thyroid dysfunction are recognized in NaProTECHNOLOGY as significant causes of cycle-level reproductive abnormalities -- including oligomenorrhea, anovulation, luteal phase deficiency, heavy bleeding, and recurrent early pregnancy loss -- detectable through CrMS charting before standard screening would prompt thyroid evaluation. The chapter advocates comprehensive thyroid assessment (TSH, free T4, free T3, and thyroid antibodies) with fertility-optimized reference thresholds in women presenting with cycle disorders or infertility, followed by reassessment of CrMS patterns and hormone profiles after thyroid correction to identify and treat any residual follicular or luteal phase defects.
Topics
Cite this article
Hilgers, T. W. (2004). Chapter 36: Thyroid System Dysfunction. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 453-466.
Hilgers TW. Chapter 36: Thyroid System Dysfunction. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:453-466.
Hilgers, T. W. "Chapter 36: Thyroid System Dysfunction." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 453-466.